Causaly provides Covid-19 dataset to Bill and Melinda Gates' funded Global Health Drug Discovery Institute

Noelle Baquiche
Noelle Baquiche
published on March 05, 2020

At Causaly, we're honored to be supporting the 2019-nCoV Collective Research Initiative led by the Global Health Drug Discovery Institute in Beijing (GHDDI).

Launched on the 27th January in partnership with the School of Pharmaceutical Sciences (SPS) and Tsinghua University, the initiative is designed to make internal drug discovery platforms and resources available to external researchers to aid drug discovery efforts against the novel coronavirus (2019-nCoV) outbreak.

Causaly has machine-read, analyzed and mapped all existing knowledge on the corona virus genus, and supplied it to the initiative's information sharing platform, to support data collection efforts.

The main contents of the GHDDI 2019-nCoV platform include:

  1. Data mining and integration of historical drug discovery efforts against coronavirus (e.g. SARS/MERS) using AI and big data;

  2. Relevant preclinical and clinical data resources;

  3. Molecular chemical modeling and simulation data using computational tools;

  4. Latest scientific research progress on 2019-nCoV.

As part of our ongoing efforts to support Open Science and accelerate research into COVID-19, we are offering complimentary accounts for Causaly's open research dataset for all non-commercial research.

(open access is no longer available as it ended in September 2020)

Get in touch to request access, or for more information.

Announcing Causaly Connect: A virtual meeting of Life Science leaders

On October 4-6, Life Science professionals from across the globe will meet virtually for Causaly Connect – an insightful series of...

Why poor target validation is costing pharmaceutical businesses millions

It has been well documented that only 1 out of 10 compounds that enter clinical trials makes it to market¹. That is an astonishing 90%...

  • Point of View

Watch Causaly’s panel discussion from Discovery Europe

On June 9th – 10th 2022, over 400 pharma leaders came to Berlin to take part in Discovery Europe...

  • General

Sign up for Causaly newsletter